Preclinical Drug Metabolism and Pharmacokinetics, and Prediction of Human Pharmacokinetics and Efficacious Dose of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237)

By  

Drug Metabolism Letters, Vol. 7, Iss. 2, 2014-05 ,pp. : 96-104

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes

By Zager Michael   Kozminski Kirk   Pascual Bernadette   Ogilvie Kathleen   Sun Shaoxian  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 41, Iss. 2, 2014-04 ,pp. : 127-139

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches

By Ito Kiyomi   Houston J. Brian  

Pharmaceutical Research, Vol. 22, Iss. 1, 2005-01 ,pp. : 103-112

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical Data: Comparative Evaluation of Prediction Approaches in Early Pharmaceutical Discovery

By >  

Clinical Pharmacokinetics, Vol. 50, Iss. 8, 2011-08 ,pp. : 505-517

Adis International

Access to resources Recommend Favorite

Methodological Uncertainty in Quantitative Prediction of Human Hepatic Clearance from In Vitro Experimental Systems

By  

Current Drug Metabolism, Vol. 10, Iss. 3, 2009-03 ,pp. : 307-321

Bentham Science Publishers

Access to resources Recommend Favorite